Ontology highlight
ABSTRACT: Introduction
Low ankle-brachial index (ABI) ≤0. 9 is a marker for generalized atherosclerosis and a risk factor for cognitive decline in the general population.Objective
To evaluate the impact of ABI ≤0.9 on cognitive function up to 3 years after first-ever ischemic stroke.Methods
Data was used from the "PROspective Cohort with Incident Stroke-Berlin" (PROSCIS-B; NCT01363856). ABI was measured at baseline and categorized into normal (1.4-0.9) vs. low (≤0.9). Cognitive function was assessed with the Montreal Cognitive Assessment (MoCA) and the Mini-Mental-State-Examination (MMSE) at baseline and with the Telephone Interview for Cognitive Status-modified (TICS-m) at 1-3 years of follow-up. We performed confounder adjusted generalized linear models (GLM) to calculate relative risks (RR) for cognitive impairment at baseline (MMSE≤26; MoCA≤25) and linear mixed models (LMM) to estimate the impact of low ABI on TICS-m over time.Results
We included 325 patients [mean age: 66 (SD = 13); 38% female, median NIHSS = 2 (IQR = 1-4), ABI≤0.9: 59 (18%)]. Patients with low ABI were at increased risk of cognitive impairment at baseline (adjusted RR for MoCA≤25 = 1.98; 95%-CI:1.24 to 3.16). TICS-m scores were consistently lower over time in patients with low ABI (adjusted ß = -1.96; 95%-CI:-3.55 to -0.37). Independent of ABI, cognitive function did not decline over time (adjusted ß:0.29; 95%-CI:-0.06 to 0.64).Conclusion
In patients with mild to moderate first-ever ischemic stroke, low ABI is associated with reduced cognitive function over a 3-year follow-up.Study registration
https://clinicaltrials.gov; Unique identifier: NCT01363856.
SUBMITTER: Stillfried MRV
PROVIDER: S-EPMC9554657 | biostudies-literature | 2022
REPOSITORIES: biostudies-literature
Stillfried Maria R V MRV Sperber Pia S PS Broersen Leonie H A LHA Huo Shufan S Piper Sophie K SK Heuschmann Peter U PU Endres Matthias M Siegerink Bob B Liman Thomas G TG
Frontiers in neurology 20220928
<h4>Introduction</h4>Low ankle-brachial index (ABI) ≤0. 9 is a marker for generalized atherosclerosis and a risk factor for cognitive decline in the general population.<h4>Objective</h4>To evaluate the impact of ABI ≤0.9 on cognitive function up to 3 years after first-ever ischemic stroke.<h4>Methods</h4>Data was used from the "PROspective Cohort with Incident Stroke-Berlin" (PROSCIS-B; NCT01363856). ABI was measured at baseline and categorized into normal (1.4-0.9) vs. low (≤0.9). Cognitive fun ...[more]